Announcements Trials
Browse Landscape

Status

Recruiting 9Active not recruiting 9Not yet recruiting 4Completed 3Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Hematologic Neoplasms 1

Interventions

Methods 2Interviews as Topic 2Educational Status 2Early Intervention, Educational 2Counseling 2sacituzumab govitecan 1pembrolizumab 1ibrutinib 1futibatinib 1erdafitinib 1enfortumab vedotin 1durvalumab 1avelumab 1Vinblastine 1Tramadol 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Standard of Care 1Specimen Handling 1Robotic Surgical Procedures 1Relaxation Therapy 1Radiotherapy, Adjuvant 1Pregabalin 1Practice Guidelines as Topic 1Platinum Compounds 1Photochemotherapy 1Patient Navigation 1Palliative Care 1Paclitaxel 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Surveys and Questionnaires × 30 days × Clear all
NCT06967467 2026-06-05

RENEW-EVAL

Abramson Cancer Center at Penn Medicine

Enrolling by invitation
80 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡